Copyright Reports & Markets. All rights reserved.

Global Transmucosal Drug Delivery Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Transmucosal Drug Delivery Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Product
      • 1.4.2 Passive Transdermal Drug Delivery
      • 1.4.3 Active Transdermal Drug Delivery
    • 1.5 Market by End User
      • 1.5.1 Global Transmucosal Drug Delivery Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Transmucosal Drug Delivery Market Size
      • 2.1.1 Global Transmucosal Drug Delivery Revenue 2014-2025
      • 2.1.2 Global Transmucosal Drug Delivery Sales 2014-2025
    • 2.2 Transmucosal Drug Delivery Growth Rate by Regions
      • 2.2.1 Global Transmucosal Drug Delivery Sales by Regions
      • 2.2.2 Global Transmucosal Drug Delivery Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Transmucosal Drug Delivery Sales by Manufacturers
      • 3.1.1 Transmucosal Drug Delivery Sales by Manufacturers
      • 3.1.2 Transmucosal Drug Delivery Sales Market Share by Manufacturers
      • 3.1.3 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.2 Transmucosal Drug Delivery Revenue by Manufacturers
      • 3.2.1 Transmucosal Drug Delivery Revenue by Manufacturers (2014-2019)
      • 3.2.2 Transmucosal Drug Delivery Revenue Share by Manufacturers (2014-2019)
    • 3.3 Transmucosal Drug Delivery Price by Manufacturers
    • 3.4 Transmucosal Drug Delivery Manufacturing Base Distribution, Product Types
      • 3.4.1 Transmucosal Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Transmucosal Drug Delivery Product Type
      • 3.4.3 Date of International Manufacturers Enter into Transmucosal Drug Delivery Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Transmucosal Drug Delivery Sales by Product
    • 4.2 Global Transmucosal Drug Delivery Revenue by Product
    • 4.3 Transmucosal Drug Delivery Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Transmucosal Drug Delivery Breakdown Data by End User

    6 North America

    • 6.1 North America Transmucosal Drug Delivery by Countries
      • 6.1.1 North America Transmucosal Drug Delivery Sales by Countries
      • 6.1.2 North America Transmucosal Drug Delivery Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Transmucosal Drug Delivery by Product
    • 6.3 North America Transmucosal Drug Delivery by End User

    7 Europe

    • 7.1 Europe Transmucosal Drug Delivery by Countries
      • 7.1.1 Europe Transmucosal Drug Delivery Sales by Countries
      • 7.1.2 Europe Transmucosal Drug Delivery Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Transmucosal Drug Delivery by Product
    • 7.3 Europe Transmucosal Drug Delivery by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Transmucosal Drug Delivery by Countries
      • 8.1.1 Asia Pacific Transmucosal Drug Delivery Sales by Countries
      • 8.1.2 Asia Pacific Transmucosal Drug Delivery Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Transmucosal Drug Delivery by Product
    • 8.3 Asia Pacific Transmucosal Drug Delivery by End User

    9 Central & South America

    • 9.1 Central & South America Transmucosal Drug Delivery by Countries
      • 9.1.1 Central & South America Transmucosal Drug Delivery Sales by Countries
      • 9.1.2 Central & South America Transmucosal Drug Delivery Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Transmucosal Drug Delivery by Product
    • 9.3 Central & South America Transmucosal Drug Delivery by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Transmucosal Drug Delivery by Countries
      • 10.1.1 Middle East and Africa Transmucosal Drug Delivery Sales by Countries
      • 10.1.2 Middle East and Africa Transmucosal Drug Delivery Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Transmucosal Drug Delivery by Product
    • 10.3 Middle East and Africa Transmucosal Drug Delivery by End User

    11 Company Profiles

    • 11.1 3M Pharmaceuticals
      • 11.1.1 3M Pharmaceuticals Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Products Offered
      • 11.1.5 3M Pharmaceuticals Recent Development
    • 11.2 Acrux Limited
      • 11.2.1 Acrux Limited Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Acrux Limited Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Acrux Limited Transmucosal Drug Delivery Products Offered
      • 11.2.5 Acrux Limited Recent Development
    • 11.3 ALZA Corporation
      • 11.3.1 ALZA Corporation Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 ALZA Corporation Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 ALZA Corporation Transmucosal Drug Delivery Products Offered
      • 11.3.5 ALZA Corporation Recent Development
    • 11.4 Antares Pharma, Inc.
      • 11.4.1 Antares Pharma, Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Products Offered
      • 11.4.5 Antares Pharma, Inc. Recent Development
    • 11.5 Apricus BioSciences, Inc
      • 11.5.1 Apricus BioSciences, Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Products Offered
      • 11.5.5 Apricus BioSciences, Inc Recent Development
    • 11.6 Aveva Drug Delivery Systems
      • 11.6.1 Aveva Drug Delivery Systems Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Products Offered
      • 11.6.5 Aveva Drug Delivery Systems Recent Development
    • 11.7 Corium International, Inc
      • 11.7.1 Corium International, Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Corium International, Inc Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Corium International, Inc Transmucosal Drug Delivery Products Offered
      • 11.7.5 Corium International, Inc Recent Development
    • 11.8 DURECT Corporation
      • 11.8.1 DURECT Corporation Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 DURECT Corporation Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 DURECT Corporation Transmucosal Drug Delivery Products Offered
      • 11.8.5 DURECT Corporation Recent Development
    • 11.9 Generex Biotechnology Corporation
      • 11.9.1 Generex Biotechnology Corporation Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Products Offered
      • 11.9.5 Generex Biotechnology Corporation Recent Development
    • 11.10 Inovio Pharmaceuticals, Inc.
      • 11.10.1 Inovio Pharmaceuticals, Inc. Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Products Offered
      • 11.10.5 Inovio Pharmaceuticals, Inc. Recent Development
    • 11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
    • 11.12 MedPharm LTD
    • 11.13 Mylan, Inc.
    • 11.14 Nemaura Pharma Ltd
    • 11.15 Nitto Denko Corporation
    • 11.16 Noven Pharmaceuticals, Inc.
    • 11.17 Pantec Biosolutions AG
    • 11.18 Tapemark
    • 11.19 tesa Labtec GmbH
    • 11.20 TEVA Pharmaceutical Industries Ltd.
    • 11.21 Zosano Pharma

    12 Future Forecast

    • 12.1 Transmucosal Drug Delivery Market Forecast by Regions
      • 12.1.1 Global Transmucosal Drug Delivery Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Transmucosal Drug Delivery Revenue Forecast by Regions 2019-2025
    • 12.2 Transmucosal Drug Delivery Market Forecast by Product
      • 12.2.1 Global Transmucosal Drug Delivery Sales Forecast by Product 2019-2025
      • 12.2.2 Global Transmucosal Drug Delivery Revenue Forecast by Product 2019-2025
    • 12.3 Transmucosal Drug Delivery Market Forecast by End User
    • 12.4 North America Transmucosal Drug Delivery Forecast
    • 12.5 Europe Transmucosal Drug Delivery Forecast
    • 12.6 Asia Pacific Transmucosal Drug Delivery Forecast
    • 12.7 Central & South America Transmucosal Drug Delivery Forecast
    • 12.8 Middle East and Africa Transmucosal Drug Delivery Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Transmucosal Drug Delivery Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Transmucosal Drug Delivery market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transmucosal Drug Delivery market based on company, product type, end user and key regions.

      This report studies the global market size of Transmucosal Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transmucosal Drug Delivery in these regions.
      This research report categorizes the global Transmucosal Drug Delivery market by top players/brands, region, type and end user. This report also studies the global Transmucosal Drug Delivery market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      3M Pharmaceuticals
      Acrux Limited
      ALZA Corporation
      Antares Pharma, Inc.
      Apricus BioSciences, Inc
      Aveva Drug Delivery Systems
      Corium International, Inc
      DURECT Corporation
      Generex Biotechnology Corporation
      Inovio Pharmaceuticals, Inc.
      Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
      MedPharm LTD
      Mylan, Inc.
      Nemaura Pharma Ltd
      Nitto Denko Corporation
      Noven Pharmaceuticals, Inc.
      Pantec Biosolutions AG
      Tapemark
      tesa Labtec GmbH
      TEVA Pharmaceutical Industries Ltd.
      Zosano Pharma

      Market size by Product
      Passive Transdermal Drug Delivery
      Active Transdermal Drug Delivery
      Market size by End User
      Hospital
      Clinic
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Transmucosal Drug Delivery market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Transmucosal Drug Delivery market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Transmucosal Drug Delivery companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Transmucosal Drug Delivery submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Transmucosal Drug Delivery are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transmucosal Drug Delivery market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now